Orbem

Summary

Seedtable Score

69

Locations

• Munich

Company Size

• 51 - 101

Last Stage Round

• Series A

Industry

• AI
• Health Tech

Insights

Orbem, based in Munich, offers an AI-powered MRI platform for scanning biological samples. Operating as a B2B SaaS company, Orbem leverages artificial intelligence to enhance the accuracy and speed of MRI diagnostics, providing an advantage over traditional manual systems. By automating the MRI scanning process, Orbem improves diagnostic precision and reduces labor costs, making it an attractive option for healthcare providers. Supported by investors like 83North, TVC, and Possible Ventures, Orbem is poised to disrupt current diagnostic practices and capture market share in the health tech sector.

• Series A (2023-11-01) $31.8M

---

• Seed (2022-01-01) $5.4M

---

Investors

• 83North Series A

---

• 83North Series A

---

• TVC Series A

---

• Possible Ventures Series A

---

• Possible Ventures Series A

---

• TVC Seed

---

• Possible Ventures Seed

---

• Possible Ventures Seed

---

Full Company Profile

Access details of the company management, and other intelligence on this company by registering for Seedtable

---